BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 7601633)

  • 41. Enhanced IL-10 and decreased IL-2 production after orthotopic corneal transplantation in mice.
    Hasková Z; Filipec M; Holán V
    Folia Biol (Praha); 1999; 45(1):21-5. PubMed ID: 10732714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
    Qian J; Hashimoto T; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice.
    Sano Y; Ksander BR; Streilein JW
    Transpl Immunol; 1996 Mar; 4(1):53-6. PubMed ID: 8762011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Major histocompatibility complex semi-matching improves murine corneal allograft survival under oxidative macrophage dominancy.
    Yamada J; Hamuro J; Terai K; Kinoshita S
    Transplantation; 2007 Oct; 84(7):899-907. PubMed ID: 17984844
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
    Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
    Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on the induction of tolerance to alloantigens. III. Induction of antibodies directed against alloantigen-specific delayed-type hypersensitivity T cells by a single injection of allogeneic lymphocytes via portal venous route.
    Sato S; Qian JH; Kokudo S; Ikegami R; Suda T; Hamaoka T; Fujiwara H
    J Immunol; 1988 Feb; 140(3):717-22. PubMed ID: 2448373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [CTLA4-Ig prevents corneal allograft rejection in mice].
    Shi WY; Xie LX
    Zhonghua Yan Ke Za Zhi; 2004 Oct; 40(10):696-700. PubMed ID: 16200862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphocytes capable of mediating delayed-type hypersensitivity reactions accumulate within sponge matrix allografts.
    Ascher NL; Cahill DR; Hoffman RA; Simmons RL
    Surgery; 1986 Aug; 100(2):321-8. PubMed ID: 2943037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
    Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV
    Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppressor T cell recognition of major and minor histocompatibility alloantigens: selected suppression of MHC-directed responses by minor alloantigen Ts.
    Perry LL; Williams IR; Dirusso S
    J Immunol; 1984 Jul; 133(1):16-23. PubMed ID: 6202781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD4+ T cells are critical for corneal, but not skin, allograft rejection.
    Haskova Z; Usiu N; Pepose JS; Ferguson TA; Stuart PM
    Transplantation; 2000 Feb; 69(4):483-7. PubMed ID: 10708099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute cell-mediated rejection in orthotopic pig-to-mouse corneal xenotransplantation.
    Oh JY; Kim MK; Ko JH; Lee HJ; Kim Y; Park CS; Park CG; Kim SJ; Wee WR; Lee JH
    Xenotransplantation; 2009; 16(2):74-82. PubMed ID: 19392722
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
    Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
    Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Initial study on mechanism of a small non-peptidic CD4 inhibitor J2 in prevention corneal allograft rejection].
    Zhang H; Xiao H; Wang DJ; Zhang L; Wang LQ; Li Y; Huang YF
    Zhonghua Yan Ke Za Zhi; 2010 Jan; 46(1):51-5. PubMed ID: 20388323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
    Hori J; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ocular resurfacing and alloepithelial rejection in a murine keratoepithelioplasty model.
    Yao YF; Inoue Y; Miyazaki D; Shimomura Y; Ohashi Y; Tano Y
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2623-33. PubMed ID: 7499085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants.
    Zhu SN; Yamada J; Streilein JW; Dana MR
    Transplantation; 2000 Mar; 69(5):1008-13. PubMed ID: 10755569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.